ALBERT DAVID
Back to Balance Sheet
|
ALBERT DAVID Last 5 Year Contingent Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹4.52 Cr | ₹1.96 Cr | ₹1.63 Cr | ₹4.03 Cr | ₹4.14 Cr |
What is the latest Contingent Liabilities ratio of ALBERT DAVID ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹4.52 Cr |
Mar2023 | ₹1.96 Cr |
Mar2022 | ₹1.63 Cr |
Mar2021 | ₹4.03 Cr |
Mar2020 | ₹4.14 Cr |
How is Contingent Liabilities of ALBERT DAVID Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹4.52 Cr | 130.38 | |
Mar2023 | ₹1.96 Cr | 20.22 | |
Mar2022 | ₹1.63 Cr | -59.46 | |
Mar2021 | ₹4.03 Cr | -2.78 | |
Mar2020 | ₹4.14 Cr | - |
Compare Contingent Liabilities of peers of ALBERT DAVID
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALBERT DAVID | ₹493.0 Cr | 1.7% | 4.8% | -27.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,420.0 Cr | -0.2% | -2.9% | 12.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,572.0 Cr | 0.3% | 6.5% | 49% | Stock Analytics | |
CIPLA | ₹123,329.0 Cr | 1.1% | 1.8% | -1.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,396.0 Cr | -0.2% | 9.5% | 12.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,956.0 Cr | 1.9% | 0.4% | 14% | Stock Analytics |
ALBERT DAVID Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALBERT DAVID | 1.7% |
4.8% |
-27.7% |
SENSEX | -0.8% |
-0.9% |
6.9% |
You may also like the below Video Courses